Hiranuma K, Tamaki S, Nishimura Y, Kusuki S, Isogawa M, Kim G, Kaito M, Kuribayashi K, Adachi Y, Yasutomi Y
J Gen Virol. 1999 Jan;80 ( Pt 1):187-193. doi: 10.1099/0022-1317-80-1-187.
The capacity of novel subunit vaccines to generate cytotoxic T lymphocytes (CTLs) against hepatitis C virus (HCV) was assessed. BALB/c mice were immunized with peptides based on the CTL and helper T cell (Th) epitopes of the HCV core, with a mixture of CTL and Th peptides (CTL+Th) or with a conjugated Th-CTL peptide. Mice immunized with CTL, CTL+Th and Th-CTL peptides, but not those immunized with Th peptide, developed HCV core CTL epitope-specific effector cells. Cytotoxic activity induced by immunization with Th-CTL was much higher than that induced by immunization with CTL+Th or CTL alone. However, rapid and high cytotoxic activities against HCV core were not only detected after immunization with peptides containing the CTL epitope but also as a result of infection with recombinant vaccinia virus carrying the HCV core gene after immunization with the Th epitope alone. Immunization with peptides containing the Th epitope also elicited spleen cell proliferation. This study demonstrates the capacity of both Th and CTL activated peptide vaccines to elicit CD8+, MHC class I-restricted CTLs. The capacity of such CTLs to contribute towards a protective and/or pathogenic immune response against HCV can now be assessed in mouse models.
评估了新型亚单位疫苗产生针对丙型肝炎病毒(HCV)的细胞毒性T淋巴细胞(CTL)的能力。用基于HCV核心的CTL和辅助性T细胞(Th)表位的肽、CTL和Th肽的混合物(CTL+Th)或缀合的Th-CTL肽免疫BALB/c小鼠。用CTL、CTL+Th和Th-CTL肽免疫的小鼠,而不是用Th肽免疫的小鼠,产生了HCV核心CTL表位特异性效应细胞。用Th-CTL免疫诱导的细胞毒性活性远高于用CTL+Th或单独CTL免疫诱导的细胞毒性活性。然而,不仅在用含CTL表位的肽免疫后检测到针对HCV核心的快速且高的细胞毒性活性,在用单独的Th表位免疫后感染携带HCV核心基因的重组痘苗病毒也导致了这种活性。用含Th表位的肽免疫也引发了脾细胞增殖。本研究证明了Th和CTL激活的肽疫苗均有能力引发CD8+、MHC I类限制性CTL。现在可以在小鼠模型中评估此类CTL对针对HCV的保护性和/或致病性免疫反应的贡献能力。